NIH AIDS Research Council to Meet Virtually and In-Person June 25
Published Date: 5/1/2026
Notice
Summary
The Office of AIDS Research Advisory Council is holding its 72nd meeting on June 25, 2026, to talk about the latest HIV research funded by the NIH. Anyone interested can join online or in person (space permitting) without registering, and they can also send in comments beforehand. This meeting helps guide important decisions on HIV research funding and progress, impacting scientists and the public alike.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Join the NIH HIV Meeting Online
You can watch the Office of AIDS Research Advisory Council meeting on June 25, 2026 (12:00 p.m. to 4:30 p.m.) via the NIH Videocast at https://videocast.nih.gov/ without registering. In-person attendance is allowed only if space is available.
Campus Entry Requires ID and Vehicle Inspections
If you plan to attend the meeting on-site at 5601 Fishers Lane, Rockville, MD, you must show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and all visitor vehicles — including taxis, hotel, and airport shuttles — will be inspected before being allowed on campus.
Request Special Accommodations in Advance
If you need special assistance (for example, sign language interpretation) to attend the June 25, 2026 meeting, you should inform the listed Contact Person in advance so reasonable accommodations can be provided.
Public May Submit Written Comments
Anyone interested may file written comments with the committee before the meeting by forwarding a statement (including name, address, telephone number, and, if applicable, business or professional affiliation) to the Contact Person listed in the notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2026-08490, Notice of First Amendment to Compact With the Republic of Senegal
The U.S. and Senegal are extending their $550 million energy partnership by six months to March 2027 and adding nearly $16 million to keep projects on track. This extra time and money will help finish important electricity upgrades that lower costs and boost reliability for Senegal and American businesses there. The changes come because some work took longer than expected, but the goal stays the same: powering up Senegal’s future with stable, affordable energy.
Next: 2026-08492, National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting
The National Institute of Biomedical Imaging and Bioengineering is holding a meeting on May 20, 2026, open to the public both in person and online. They’ll share updates and review grant applications, some parts behind closed doors to protect privacy and secrets. If you’re interested, you can watch online or send in your comments before the meeting!